Biomarkers in Patients With Rhabdomyosarcoma

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

May 31, 2016

Conditions
Sarcoma
Interventions
GENETIC

DNA methylation analysis

GENETIC

fluorescence in situ hybridization

GENETIC

gene expression analysis

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

laboratory biomarker analysis

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Children's Oncology Group

NETWORK

NCT01466283 - Biomarkers in Patients With Rhabdomyosarcoma | Biotech Hunter | Biotech Hunter